can glutathione cause elevated liver enzymes A Literature Review of Therapy in Ameliorating Hepatic Dysfunction in Non-Alcoholic Fatty Disease Disruption in glutathione metabolism and
Description
BPC 157 antagonized portal/caval hypertension (caval portal hypertension), and aortal hypotension, refractory ascites and thrombosis (portal vein tributaries, inferior vena cava, hepatic and coronary arteries), pathology of the lungs (severe capillary congestion) and liver (dilated central veins and terminal portal venules), intestine hemorrhagic lesions (substantial capillary congestion, submucosal edema and architecture loss), increased liver and spleen weight serum and enzymes values, NO- and MDA-levels in the liver

How Long Until I See Results With BPC 157

This treatment is commonly used to support cognitive performance, muscle recovery, and overall physiologic resilience under medical supervision

10.1080/08923973.2016.1274997 40 RaineT.BonovasS.BurischJ.KucharzikT.AdaminaM.AnneseV.et al (2022)

So, lets unpack the reality of GHK-Cu's status, not with speculation, but with a clear-eyed look at the facts
